Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Argus Health
Citi
Medtronic
UBS
Teva

Generated: July 16, 2019

DrugPatentWatch Database Preview

Patent: 8,911,426

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,911,426
Title:Low-permeability, laser-activated drug delivery device
Abstract: An implantable drug delivery device that uses multiple reservoir elements to contain and release doses of active pharmaceutical ingredients. The device includes a first shell element, which has a first enclosed cavity volume and forms a low-permeability barrier. The first shell element is configured to absorb light irradiation from a laser source, the laser irradiation causing a breach in the first shell element. A first active pharmaceutical ingredient is contained in the first enclosed cavity volume and is released when the first shell element is breached. The device also includes a second shell element, which has a second enclosed cavity volume and also forms a low-permeability barrier. A second active pharmaceutical ingredient is contained in the second enclosed cavity volume. The device also includes an envelope element containing the first and second shell elements.
Inventor(s): Coppeta; Jonathan Robert (Windham, NH), Horne; Kenneth N. (San Francisco, CA), Santini, Jr.; John T. (North Chelmsford, MA), Scholl; John A. (San Ramon, CA), Spooner; Gregory J. R. (San Francisco, CA), Stevenson; Cynthia L. (Mountain View, CA), Shams; Naveed (Danville, CA), Poutiatine; Andrew (Mill Valley, CA)
Assignee: On Demand Therapeutics, Inc. (Tyngsboro, MA)
Application Number:13/023,370
Patent Claims:see list of patent claims

Details for Patent 8,911,426

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Regeneron Pharmaceuticals EYLEA aflibercept INJECTABLE; INJECTION 125387 001 2011-11-18 ➤ Try a Free Trial On Demand Therapeutics, Inc. (Tyngsboro, MA) ➤ Try a Free Trial RX search
Genentech LUCENTIS ranibizumab INJECTABLE; INJECTION 125156 001 2006-06-30 ➤ Try a Free Trial On Demand Therapeutics, Inc. (Tyngsboro, MA) ➤ Try a Free Trial RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Try a Free Trial On Demand Therapeutics, Inc. (Tyngsboro, MA) ➤ Try a Free Trial RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Try a Free Trial On Demand Therapeutics, Inc. (Tyngsboro, MA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
Farmers Insurance
Cantor Fitzgerald
UBS
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.